Literature DB >> 33500728

Eradication of solid tumors by chemodynamic theranostics with H2O2-catalyzed hydroxyl radical burst.

Nana Wang1,2, Qin Zeng1,2, Ruijing Zhang1,2, Da Xing1,2, Tao Zhang1,2.   

Abstract

Activatable theranostics, integrating high diagnostic accuracy and significant therapeutic effect, holds great potential for personalized cancer treatments; however, their chemodynamic modality is rarely exploited. Herein, we report a new in situ activatable chemodynamic theranostics PAsc/Fe@Cy7QB to specifically recognize and eradicate cancer cells with H2O2-catalyzed hydroxyl radical (•OH) burst cascade.
Methods: The nanomicelles PAsc/Fe@Cy7QB were constructed by self-assembly of acid-responsive copolymers incorporating ascorbates and acid-sensitive Schiff base-Fe2+ complexes as well as H2O2-responsive adjuvant Cy7QB.
Results: Upon systematic delivery of PAsc/Fe@Cy7QB into cancer cells, the acidic microenvironment triggered disassembly of the nanomicelles. The released Fe2+ catalyzed the oxidation of ascorbate monoanion (AscH-) to efficiently produce H2O2. The released H2O2, together with the endogenous H2O2, could be converted into highly active •OH via the Fenton reaction, resulting in enhanced Fe-mediated T1 magnetic resonance imaging (MRI). The synchronously released Cy7QB was activated by H2O2 to produce a glutathione (GSH)-scavenger quinone methide to boost the •OH yield and recover the Cy7 dye for fluorescence and photoacoustic imaging.
Conclusion: The biodegradable PAsc/Fe@Cy7QB designed for tumor-selective multimodal imaging and high therapeutic effect provides an exemplary paradigm for precise chemodynamic theranostic. © The author(s).

Entities:  

Keywords:  Fenton reaction; activatable; chemodynamic theranostics; multimodal imaging; reactive oxygen species

Year:  2021        PMID: 33500728      PMCID: PMC7797687          DOI: 10.7150/thno.49277

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  82 in total

1.  Engineered Bacterial Bioreactor for Tumor Therapy via Fenton-Like Reaction with Localized H2 O2 Generation.

Authors:  Jin-Xuan Fan; Meng-Yun Peng; He Wang; Hao-Ran Zheng; Zong-Lin Liu; Chu-Xin Li; Xia-Nan Wang; Xin-Hua Liu; Si-Xue Cheng; Xian-Zheng Zhang
Journal:  Adv Mater       Date:  2019-02-25       Impact factor: 30.849

2.  Engineering Magnetosomes for Ferroptosis/Immunomodulation Synergism in Cancer.

Authors:  Fan Zhang; Feng Li; Gui-Hong Lu; Weidong Nie; Lijun Zhang; Yanlin Lv; Weier Bao; Xiaoyong Gao; Wei Wei; Kanyi Pu; Hai-Yan Xie
Journal:  ACS Nano       Date:  2019-05-06       Impact factor: 15.881

Review 3.  Nanotechnology for Multimodal Synergistic Cancer Therapy.

Authors:  Wenpei Fan; Bryant Yung; Peng Huang; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2017-10-19       Impact factor: 60.622

4.  Photothermal-pH-hypoxia responsive multifunctional nanoplatform for cancer photo-chemo therapy with negligible skin phototoxicity.

Authors:  Dapeng Chen; Yunyun Tang; Jiawei Zhu; Jiaojiao Zhang; Xuejiao Song; Wenjun Wang; Jinjun Shao; Wei Huang; Peng Chen; Xiaochen Dong
Journal:  Biomaterials       Date:  2019-08-12       Impact factor: 12.479

Review 5.  Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy.

Authors:  Huanli Sun; Yifan Zhang; Zhiyuan Zhong
Journal:  Adv Drug Deliv Rev       Date:  2018-05-24       Impact factor: 15.470

6.  Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.

Authors:  Lili Feng; Rui Xie; Chuanqing Wang; Shili Gai; Fei He; Dan Yang; Piaoping Yang; Jun Lin
Journal:  ACS Nano       Date:  2018-10-25       Impact factor: 15.881

7.  An Adenosine Triphosphate-Responsive Autocatalytic Fenton Nanoparticle for Tumor Ablation with Self-Supplied H2O2 and Acceleration of Fe(III)/Fe(II) Conversion.

Authors:  Lu Zhang; Shuang-Shuang Wan; Chu-Xin Li; Lu Xu; Han Cheng; Xian-Zheng Zhang
Journal:  Nano Lett       Date:  2018-11-07       Impact factor: 11.189

8.  A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan.

Authors:  Yoko Yoshida; Toshiyuki Miyata; Masanori Matsumoto; Hiroko Shirotani-Ikejima; Yumiko Uchida; Yoshifumi Ohyama; Tetsuro Kokubo; Yoshihiro Fujimura
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

9.  Iron oxide nanozyme suppresses intracellular Salmonella Enteritidis growth and alleviates infection in vivo.

Authors:  Shourong Shi; Shu Wu; Yiru Shen; Shan Zhang; Yunqi Xiao; Xi He; Jiansen Gong; Yuhua Farnell; Yan Tang; Yixin Huang; Lizeng Gao
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

Review 10.  Ferritins as natural and artificial nanozymes for theranostics.

Authors:  Bing Jiang; Long Fang; Kongming Wu; Xiyun Yan; Kelong Fan
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more
  2 in total

1.  A microenvironment-responsive FePt probes for imaging-guided Fenton-enhanced radiotherapy of hepatocellular carcinoma.

Authors:  Xingyang Zhao; Xiang Sun; Wenchao Huang; Ronghe Chen; Kang Chen; Liming Nie; Chihua Fang
Journal:  J Nanobiotechnology       Date:  2022-03-03       Impact factor: 10.435

2.  Dual-dynamic-bond cross-linked injectable hydrogel of multifunction for intervertebral disc degeneration therapy.

Authors:  Linjun Yang; Congcong Yu; Xuhui Fan; Tianni Zeng; Wentao Yang; Jiechao Xia; Jianle Wang; Litao Yao; Chuan Hu; Yang Jin; Yutao Zhu; Jiaxin Chen; Zhijun Hu
Journal:  J Nanobiotechnology       Date:  2022-10-01       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.